Physicochemical and physiological considerations for efficient nose-to-brain targeting

Bibliography

• Chugh Y, Kapoor P, Kapoor AK. Intranasal drug delivery: a novel approach. Ind J Otolaryngol Head Neck Surg 2009;61:90-4
   PubMed Web of Science ®Google Scholar
• Hanson LR, Frey WH. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 2008;9:1-5
   PubMed Web of Science ®Google Scholar
• Jain R, Nabar S, Dandekar P, Micellar nanocarriers: Potentail nose-to- brain delivery of zolmitriptan as novel migraine therapy. Pharm Res 2010;29(4):655-64
   Google Scholar
• D'suza R, Mutalik S, Venkatesh M, Nasal insulin gel as an alternative to parenteral insulin: formulation preclinical and clinical studies. AAPS PharmSciTech 2005;6:184-90
   Google Scholar
• Ugwoke MI, Agu RU, Verbeke N, Nasal mucoadhesive drug delivery: bachground, applications, trends and future perspectives. Adv Drug Deliv Rev 2005;57:1640-65
   PubMed Web of Science ®Google Scholar
• Wang D, Gao Y, Yan L. Study on brain targeting of raltitrexed following intranasal administration in rats. Cancer Chemother Pharmacol 2005;57:97-104
   PubMed Web of Science ®Google Scholar
• Talegaonkar S, Misra PR. Intranasal delivery: An approach to bypass the blood brain barrier. Ind J Pharmacol 2004;36(1):140-7
   Google Scholar
• Pires A, Fortuna A, Alves G, Intranasal drug delivery; How, why and what for. J Pharm Pharm Sci 2009;12(3):288-311
   PubMed Web of Science ®Google Scholar
• Wermeling DP. Intranasal delivery of antiepileptic medications for treatment of seizures. Neurotherapeutics 2009;6(2):352-8
   PubMed Web of Science ®Google Scholar
• Kumar M, Mishra A, Babbar AK, Intranasal nanoemulsion based brain targetting drug delivery system of resperidone. Int J Pharm 2008;358:285-91
   PubMed Web of Science ®Google Scholar
• Chopra K, Misra S, Kuhad A. Neurological aspects of Alzheimer's disease. Expert Opin Ther Targets 2011;15(5):535-55
   PubMed Web of Science ®Google Scholar
• Alam MA, Bega S, Samad A, Strategy for effective brain drug delivery. Eur J Pharm Sci 2010;40:385-403
   PubMed Web of Science ®Google Scholar
• Kumar M, Mishra A, Pathak K. Formulation and characterization of nanoemulsion-based drug delivery system of resperidone. Drug Dev Ind Pharm 2009;35:387-95
   PubMed Web of Science ®Google Scholar
• Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Deliv Tech 2002;7:67-97 (18)5
   Google Scholar
• Costantino HR, Illum L, Brandt G, Intranasal delivery: physiochemical and therapeutic aspects. Int J Pharm 2007;337:1-24
   PubMed Web of Science ®Google Scholar
• Illum L. Nasal drug delivery – possibilities, problems and solutions. J Control Release 2003;87:187-98
   PubMed Web of Science ®Google Scholar
• Yang J, Liu H, Cheng S, Direct transport of VEGF from the nasal cavity to brain. Neurosci Lett 2009;449:108-11
   PubMed Web of Science ®Google Scholar
• Illum L. Transport of drugs from nasal cavity to the central nervous system. Eur J Pharm Sci 2000;11:1-18
   PubMed Web of Science ®Google Scholar
• Arvizo R, Bhattacharya R, Mukherjee G. Gold nanoparticles opportunity and challenged in nanomedicine. Expert Opin Drug Deliv 2011;7(6):753-63
   Web of Science ®Google Scholar
• Khan S, Patil K, Yeole P, Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats. J Pharm Pharmacol 2009;61(5):669-75
   PubMed Web of Science ®Google Scholar
• Jadhav KR, Gambhire MN, Shaikh IM, Nasal drug delivery system-factors affecting and applications. Curr Drug Ther 2007;2:27-38
   Google Scholar
• Behl CR, Pimplaskar HK, Sileno AP, Effects of physicochemical properties and other factors on nasal drug delivery. Adv Drug Deliv Rev 1998;29:89-116
   PubMed Web of Science ®Google Scholar
• Laquintana V, Trapani A, Denora N, New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv 2009;6(10):1017-32
   PubMed Web of Science ®Google Scholar
• Turker S, Onur E, Ozer Y. Nasal route and drug delivery systems. Pharm World Sci 2004;26:137-42
   PubMed Web of Science ®Google Scholar
• Kimura R, Miwa M, Kato Y, Nasal absorption of tetraethylammonium in rats. Arch Int Pharmacodyn Ther 1989;302:7-17
   PubMedGoogle Scholar
• Harikarnpakdee S, Lipipun V, Sutanthavibul N, Spray dried mucoadhesive microspheres preparation and transport through nasal cell monolayer. AAPS PharmSciTech 2006;7:1-10
   PubMed Web of Science ®Google Scholar
• Ozsoy Y, Gungor S, Cevher L. Nasal delivery of high molecular weight drugs. Molecules 2009;14:3754-79
   PubMed Web of Science ®Google Scholar
• Henkin RI. Intranasal insulin: From nose to brain. Nutrition 2010;26:624-33
   PubMed Web of Science ®Google Scholar
• Hussain AA, Dakkuri A, Itoh S. Nasal absorption of ondansetron in rats: an alternative route of drug delivery. Cancer Chemother Pharmacol 2000;45:432-4
   PubMed Web of Science ®Google Scholar
• Illum L, Hinchelife M, David SS. The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability of drugs on administration in the sheep model. Pharm Res 2003;20:1474-85
   PubMed Web of Science ®Google Scholar
• Begley DJ. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharm Ther 2004;104:29-45
   PubMed Web of Science ®Google Scholar
• Illum L. The nasal delivery of peptides and proteins. Trends Biotech 1991;9:284-9
   PubMed Web of Science ®Google Scholar
• Yu H, Kim K. Direct nose –to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits. Int J Pharm 2009;378:73-9
   PubMedGoogle Scholar
• Illum L. Nasal drug delivery: new developments and strategies. Drug Dev Tech 2002;7(23):1184-9
   Google Scholar
• Kumar M, Mishra A, Babbar AK, Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. J Drug Target 2008;16(10):806-14
   PubMed Web of Science ®Google Scholar
• Bhise SB, Yadav AV, Avachat AM, Bioavailability of intranasal drug delivery system. Asian J Pharm 2008;2:201-15
   Google Scholar
• Berg MP, Verhoef C, Romeijn SG, Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats. Eur J Pharm Biopharm 2004;58:131-5
   PubMed Web of Science ®Google Scholar
• Jones N. The nose and paranasal sinuses physiology and anatomy. Adv Drug Deliv Rev 2001;51:5-19
   PubMed Web of Science ®Google Scholar
• Kubik H, Vidgren MT. Nasal delivery systems and their effect on deposition and absorption. Adv Drug Deliv Rev 1998;29:157-77
   PubMed Web of Science ®Google Scholar
• Kumar M, Mishra A, Pathak K. Formulation and characterization nanoemulsion of olanzapine for intranasal delivery. PDA J Pharm Sci Technol 2009;63:501-11
   PubMedGoogle Scholar
• Ying W. The nose may help the brain; intranasal drug delivery for treating neurological diseases. Future Neurol 2008;3(1):1-4
   Google Scholar
• Bhumkar DR, Joshi HM, Sastry M, Chitosan reduced gold nanoparticles as novel carriers for transdermal delivery of insulin. Pharm Res 2007;24:1415-27
   PubMed Web of Science ®Google Scholar
• Sarkar MA. Drug metabolism in nasal mucosa. Pharm Res 1992;9:1-9
   PubMed Web of Science ®Google Scholar
• Hermens W, Merkus F. The influence of drugs on ciliary movement. Pharm Res 1987;4:445-50
   PubMed Web of Science ®Google Scholar
• Wang YC, Zuo Z. Intranasal delivery- modification of drug metabolism and brain disposition. Pharm Res 2010;27:1208-23
   PubMed Web of Science ®Google Scholar
• Shao Z, Mitra AK. Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs. Pharm Res 1994;11:243-51
   PubMed Web of Science ®Google Scholar
• Stevens J, Suidgeest E, Graaf H, A new minimal – stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs. Pharm Res 2009;26:1911-19
   PubMed Web of Science ®Google Scholar
• Kushwaha SKS, Keshari RK, Rai AK. Advances in nasal trans-mucosal drug delivery. J Appl Pharm Sci 2011;7:21-8
   Google Scholar
• Csaba N, Fuentes MG, Alonso MJ. Nanoparticles for nasal vaccination. Adv Drug Deliv Rev 2009;61:140-57
   PubMed Web of Science ®Google Scholar
• Mahajan HS, Shah SK, Surana SJ. Nasal in situ gel containing hydroxyl propyl b-cyclodextrin inclusion complex of artemether: development and in vitro evaluation. J Incl Phenom Macrocyl 2010;16:1-10
   Google Scholar
• Luppi B, Bigucci F, Abruzzo A, Freeze-dried chotosan/pectin inserts for antipsychotic drug delivery. Eur J Pharm Biopharm 2001;75:381-7
   Google Scholar
• Charlton S, Jones NS, Davis SS, Distribution and clearance of bioadhesive formulations from the olfactory region in man: Effect of polymer type and nasal delivery device. Eur J Pharm Sci 2007;30:295-302
   PubMed Web of Science ®Google Scholar
• Chaudhari PV. Recent trends in nasal drug delivery – an overview. Pharmainf Net 2006;4:5.1-5
   Google Scholar
• Mistry A, Stolnic S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 2009;379:146-57
   PubMed Web of Science ®Google Scholar
• Agu R, Dang HV, Jorissen M, In–vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of of the amino acid transporters involved. Pharm Res 2003;20:1125-32
   PubMed Web of Science ®Google Scholar
• Hussain AA. Intranasal drug delivery. Int J Pharm 1998;29:39-49
   Google Scholar
• Wang D, Gao EY, Yun EL. Study on brain targeting of ralititrexed following intranasal administration in rats. Cancer Chemother Phamacol 2006;57:57-104
   Google Scholar
• Pardridge WM. Drug targeting to the brain. Pharm Res 2007;24(9):1733-42
   PubMed Web of Science ®Google Scholar
• Yyas TK, Babbar AK, Sharma PK, Preliminary brain-targeting studies on intranasal mucoadhesive microemulsion of sumatriptan. AAPS PharmSciTech 2006;7(1):E1-9
   PubMedGoogle Scholar
• Upadhyay S, Parikh A, Joshi P, Intranasal drug delivery system- a glimpse to become maestro. J Appl Pharma Sci 2011;1:34-44
   Google Scholar
• Vyas TK, Babbar AK, Sharma RK, Intranasal mucoadhesive microemulsion of zolmitriptan: Preliminary studies on brain targeting. J Drug Target 2005;13(5):45-52
   Google Scholar
• Wang X, Chi N, Tang X. Preparation of estradiol chitosan nanoparticles for improving nasal absorption. Eur J Pharm Biopharm 2008;70:735-40
   PubMed Web of Science ®Google Scholar
• Zhang Q, Jiang X, Jiang W, Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm 2004;275:85-96
   PubMed Web of Science ®Google Scholar
• Mandal S, Mandal SD. Design and development of carbamazepine mucoadhesive microemulsion for intranasal drug delivery. Int J Pharm Sci Rev Res 2010;3:56-60
   Google Scholar
• Vyas TK, Babbar AK, Sharma RK, Intranasal mucoadhesive microemulsions of clonazepam preliminary studies on brain targeting. J Pharm Sci 2006;95:1-11
   Web of Science ®Google Scholar